05-22076. National Human Genome Research Institute; Notice of Closed Meetings  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

    The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Human Genome Research Institute Special Emphasis Panel, SEP (ZHG1 HGR N J1).

    Date: November 10, 2005.

    Time: 1:30 p.m. to 4 p.m.

    Agenda: To review and evaluate grant applications.

    Place: National Institutes of Health, 5635 Fishers Lane, Bethesda, MD 20892, (Telephone Conference Call).

    Contact Person: Ken D. Nakamura, PhD, Scientific Review Administrator, Scientific Review Branch, National Human Genome Research Institute, National Institutes of Health, 5635 Fishers Lane, Suite 4076, MSC 9306, Rockville, MD 20852, 301-402-0838.

    Name of Committee: National Human Genome Research Institute Special Emphasis Panel, Design and Analysis RFA.

    Date: December 5-6, 2005.

    Time: 8:30 a.m. to 4 p.m.

    Agenda: To review and evaluate grant applications.

    Place: Double Tree Rockville, 1750 Rockville Pike, Rockville, MD 20852.

    Contact Person: Rudy O. Pozzatti, PhD, Scientific Review Administrator, Office of Scientific Review, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, 301 402-0838.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS)

    Start Signature

    Dated: October 26, 2005.

    Anthony M. Coelho, Jr.,

    Acting Director, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 05-22076 Filed 11-04-05; 8:45am]

    BILLING CODE 4140-01-M

Document Information

Comments Received:
0 Comments
Effective Date:
11/10/2005
Published:
11/07/2005
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
05-22076
Dates:
November 10, 2005.
Pages:
67495-67495 (1 pages)
PDF File:
05-22076.pdf